Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review
Authors
Keywords
Aspirin, Oral antiplatelets, P2Y12 inhibitors, Prevention
Journal
IRISH JOURNAL OF MEDICAL SCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-04
DOI
10.1007/s11845-018-1897-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dyspnea in patients treated with P2Y12 receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry
- (2017) Dimitrios Alexopoulos et al. PLATELETS
- Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionClinical Perspective
- (2016) Zuzana Motovska et al. CIRCULATION
- Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy
- (2016) Giuseppe Tarantini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
- (2015) S. Schulz-Schupke et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons
- (2015) Deanna G. Brown et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin
- (2015) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
- (2014) Ezra A. Amsterdam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
- (2014) Jean-Philippe Collet et al. LANCET
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
- (2014) Kakali Ghoshal et al. TheScientificWorldJOURNAL
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- The Influence of Omeprazole on Platelet Inhibition of Clopidogrel in Various CYP2C19 Mutant Alleles
- (2012) Qian Liu et al. Genetic Testing and Molecular Biomarkers
- A Survey of Current Practice of Venous Thromboembolism Prophylaxis in Hospitalized Inflammatory Bowel Disease Patients in the United States
- (2012) Andrew Tinsley et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) Patrick T. O'Gara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- (2011) Sidney C. Smith et al. CIRCULATION
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
- (2011) Hyeon-Cheol Gwon et al. CIRCULATION
- Individual and Population Benefits of Daily Aspirin Therapy
- (2011) Jeremy B. Sussman et al.
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial
- (2010) F. Gerald R. Fowkes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
- (2008) Hisao Ogawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started